Cargando…
Granulomatous interstitial nephritis secondary to adalimumab therapy
Tumour necrosis factor α (TNF-α) inhibitors are frequently used for the treatment of immune-mediated diseases. Conversely, cytokine therapy has the potential to paradoxically induce autoimmunity. A number of case reports have emerged concerning sarcoid-like granulomatosis secondary to TNF-α therapy,...
Autores principales: | Sandys, Vicki, Moloney, Brona, Lane, Louise, Qazi, Junaid, Doyle, Brendan, Barry, Maurice, Leavey, Sean, Conlon, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887274/ https://www.ncbi.nlm.nih.gov/pubmed/29644062 http://dx.doi.org/10.1093/ckj/sfx104 |
Ejemplares similares
-
Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis
por: Wilson, Parker C, et al.
Publicado: (2018) -
The use of gallium-67 scintigraphy in the diagnosis of acute interstitial nephritis
por: Graham, François, et al.
Publicado: (2016) -
Severe tubulointerstitial nephritis: tracking tuberculosis even in the absence of renal granuloma
por: Delafosse, Marion, et al.
Publicado: (2018) -
A Case of Adalimumab-Induced Granulomatous Interstitial Nephritis
por: Plant, Rory, et al.
Publicado: (2021) -
Treatment of sarcoid granulomatous interstitial nephritis with adalimumab
por: Gupta, Roopali, et al.
Publicado: (2009)